Procter & Gamble (P&G) has announced a $244 million investment in a new personal healthcare and digestive product manufacturing plant in Gujarat, India. The state-of-the-art facility will also serve as a major global export hub, expanding P&G's global footprint and boosting the local economy with hundreds of new jobs.
Aside from healthcare items, Procter & Gamble said it will also produce digestive products already listed in P&G's global product portfolio. The company said this week that the facility will have all of these buildings for various productions.
As per Reuters, the new plant will start its operations in a few years without giving an exact year. The company is hoping that this location in Idia will become its global export base for most of P&G's offerings.
The multi-million facility in the western part of Gujarat will sit on 50,000 square meters of land. The investment for it is set to be made via an unlisted company and will not affect any of the listed public companies within the P&G India circle.
In any case, Procter & Gamble has several plants in India, and this project is, in fact, the company's ninth factory already. The company has been producing most of its popular brands in the country, such as Whisper, Tide, Pampers, Vicks, Oral B, Head & Shoulders, Ariel, and Gillette.
"This facility will be operational over the next few years and is set to become an export hub for P&G globally, as it will help P&G India in serving consumers across the globe," the company said.
Finally, LiveMint reported that the new Procter & Gamble facility is also expected to boost the local economy. It will also generate hundreds of new jobs for the residents, so the new plant is highly beneficial in many aspects.
Photo by: P&G Multimedia


Japan's Services Sector Growth Slows in March Amid Rising Middle East Tensions
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Australia's Trade Surplus Surges in February on Gold Export Boom
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Gulf War Ceasefire Hopes Weigh on Dollar Ahead of Trump Address
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Bank of Japan Eyes Further Rate Hikes Amid Middle East Tensions and Inflation Pressures
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
U.S. Dollar Climbs as Trump Escalates Rhetoric Against Iran
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
U.S. Stock Futures Steady Amid Iran Ceasefire Talks and Trump Address
Gold Prices Drop as Trump Escalates Iran Threats, Oil Surges
Japan Business Sentiment Rises as Iran War Fuels Inflation Fears, BOJ Rate Hike Looms
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
South Korea's Inflation Rises Modestly in March Amid Oil Price Pressures
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 



